Recurrent depression
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
19
|
12
|
0.310 |
None |
1.000 |
1 |
2
|
2009 |
2009 |
Down Syndrome, Partial Trisomy 21
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
19
|
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Trisomy 21, Meiotic Nondisjunction
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
19
|
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Mercury Poisoning, Nervous System
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
3
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Cerebral Vasospasm
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
48
|
3
|
0.300 |
None |
1.000 |
1 |
|
2002 |
2002 |
Minamata Disease
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
2
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Vasogenic Cerebral Edema
|
phenotype |
Nervous System Diseases
|
Pathologic Function
|
8
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Cytotoxic Cerebral Edema
|
phenotype |
Nervous System Diseases
|
Pathologic Function
|
8
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Attention Deficit and Disruptive Behavior Disorders
|
phenotype |
Mental Disorders
|
Pathologic Function
|
2
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Cytotoxic Brain Edema
|
phenotype |
Nervous System Diseases
|
Pathologic Function
|
8
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Mercury Poisoning, Organic
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
2
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Inorganic Mercury Poisoning
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
2
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Cerebral Edema
|
phenotype |
Nervous System Diseases
|
Pathologic Function
|
26
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Vasospasm, Intracranial
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
7
|
|
0.300 |
None |
1.000 |
1 |
|
2002 |
2002 |
Mercury Psychosis
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Mental or Behavioral Dysfunction
|
2
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Neoplasms, Intracranial
|
group |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
157
|
4
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Brain Tumor, Primary
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
122
|
8
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Recurrent Brain Neoplasm
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
39
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Primary malignant neoplasm of brain
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
41
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Trisomy 21, Mitotic Nondisjunction
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
19
|
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Malignant neoplasm of brain
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
294
|
16
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Vasogenic Brain Edema
|
phenotype |
Nervous System Diseases
|
Pathologic Function
|
8
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Oppositional Defiant Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
27
|
9
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Mercury Encephalopathy
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
2
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Mad Hatter Disease
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
2
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |